General Wei Fenghe, China's defense minister, meets with his US counterpart James Mattis in Beijing, June 27, 2018. [Photo/Xinhua] Militaries from China and the United States will enhance communication and properly manage differences and risks, senior military officials said on Wednesday. China resolutely follows the path of peaceful development, and the Chinese military will adamantly protect national sovereignty, security and development interests, General Wei Fenghe, China's defense minister, said while meeting his US counterpart James Mattis in Beijing, according to a release by the Ministry of National Defense. Wei also expressed China's stance and concerns to the US top defense official over issues regarding the South China Sea, Taiwan and Korean Peninsula. China and the US can only achieve joint development by upholding mutual respect, win-win cooperation and nonconfrontational attitudes, Wei said. The two militaries should fulfill the consensus reached by both countries' State leaders, increase mutual trust and cooperation, properly manage risks, and make Sino-US military-to-military relations truly a stabilizing factor for bilateral relations, he added. Mattis said China's development is beneficial for the US and the world, and both countries should get along in harmony, according to the release. The US side values Sino-US military relations, and is willing to optimize communication channels with China to facilitate open dialogues and improve risk management, he added. It is believed that the US and China, two great nations, can facilitate world peace and development through cooperation, he said. Mattis is conducting his first visit to China from Tuesday to Thursday. It is also the first visit to China of a US defense secretary since Chuck Hagel in April 2014. customised wristbands ukblack rubber braceletssilicone wristbands24 hour wristbands couponcheap custom wristbandssilicone fidget spinnerhow to make rubber braceletsmotivational wristbands for athletesprinted bracelets
LANZHOU -- Heavy ion medical accelerators developed by Chinese researchers entered clinical testing for cancer patients in Northwest China's Gansu province this month, researchers said.Cancer radiation treatments employing heavy-ion accelerators can bombard a target with high-energy electrons to kill cancer cells.Xiao Guoqing, head of the Institute of Modern Physics under the Chinese Academy of Sciences, said it is widely considered the most effective way of fighting tumors.Compared to traditional therapy such as radiation, heavy ion treatment is considered to have more balanced properties with less radiation on healthy cells. The treatment period is shorter and the therapy could more effectively control cancer cells.The institute, based in Lanzhou, capital of northwest China's Gansu Province, developed the accelerators in 2015. It took two years for the accelerators to undergo medical equipment testing. Registration and testing were completed in April this year and clinical tests began.Currently, the institute has produced two sets of the cancer treatment equipment, one each in Lanzhou and Wuwei city, which has a high rate of stomach cancer.Patients were selected from Gansu Provincial Cancer Hospital and Wuwei Cancer Hospital. Testing is under way for cancer treatment for the head, neck, chest, abdomen, pelvis and limbs.In order to ensure the safety of the tests, 36 leading doctors in cancer treatment were assigned to oversee the tests.Xiao said the domestically developed equipment marks the end of China's dependence on imports. The institute started basic research into the technology in 1993.Currently very few hospitals in China offer heavy ion cancer treatment in China. Shanghai Proton and Heavy Ion Center uses imported equipment from Germany for cancer treatment. There is a long wait for the treatment at the Shanghai hospital.A report published by the National Cancer Center in 2017 showed that China has nearly 25 percent of the world's new cancer cases, with 10,000 cancer patients added per day. Every year, there are two million cancer-induced deaths. Lung, breast and stomach cancers are the most common types.
